NCT05062564View on ClinicalTrials.gov

Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

January 17, 2022

Study Completion Date

January 17, 2022

Conditions
Meibomian Gland DysfunctionCataractSurgery--ComplicationsDry EyeBlepharitis
Interventions
DEVICE

LipiFlow Thermal pulsation system

Single treatment with LipiFlow thermal pulsation system on the eyelids within two months before surgery

PROCEDURE

Eyelid warm compresses plus massages

Eyelid warm compresses plus massages twice a day for the preoperative month

Trial Locations (1)

50134

Eye clinic, Careggi University hospital, Florence

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria Careggi

OTHER

NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye | Biotech Hunter | Biotech Hunter